Skip to Main Content

Paper Details

Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Pediatr Blood Cancer
7
2022
Author NameAffiliation
David S ZieglerKids Cancer Centre, Sydney Children's Hospital
David S ZieglerUniversity of New South Wales
Patrick BrownJohns Hopkins University/Sidney Kimmel Cancer Center
Patrick BrownJohns Hopkins University/Sidney Kimmel Cancer Center
Van HuynhChildren's Hospital Orange County
Sima JehaSt. Jude Children's Research Hospital
  • 1 - 6

Datasets

NECTARDisease-related non-synonymous mutationsLink
NECTARDisease-related non-synonymous mutationsLink
NECTARDisease-related non-synonymous mutationsLink
NECTARDisease-related non-synonymous mutationsLink
NECTARDisease-related non-synonymous mutationsLink